The device is designed to analyse NCCT images to determine intracranial haemorrhage and large vessel occlusion suspicion. Credit: Raman Oza from Pixabay.

The US Food and Drug Administration (FDA) has granted 510(k) clearance to RapidAI’s non-contrast computerised tomography (CT) imaging solution to accelerate acute stroke triage.

Rapid NCCT (non-contrast CT) Stroke is claimed to be the first and only medical device approved by the FDA for the identification of suspected intracranial haemorrhage (ICH) and large vessel occlusion (LVO) from value-based CT imaging.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The fully automated device leverages artificial intelligence (AI) to analyse NCCT images to detect ICH and LVO in the distal internal carotid artery and middle cerebral artery.

The system sends notifications related to triage and prioritisation through picture archiving and communication systems (PACS), email and the Rapid mobile app.

RapidAI CEO Karim Karti said: “This technology will not only have an enormous impact on stroke care here in the U.S. but also globally by giving care teams at small, local or regional facilities around the world access to advanced clinical decision support technology too often only available at comprehensive stroke centres.

“Our hope is that by providing better information early for more informed treatment and transfer decisions, Rapid NCCT Stroke will support faster stroke care and better patient outcomes.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Rapid NCCT Stroke helps speed up door-to-imaging and door-to-decision time.

The system enables centres to access advanced value-based CT imaging technology for enhanced decision-making and patient outcomes.

NCCT imaging is the first-line imaging tool used for stroke and trauma patients and improved systems can facilitate faster transfer decisions.

RapidAI offers neurovascular and vascular clinical decision support and patient workflow solutions using AI.